加齢黄斑変性（AMD）の世界市場 2024-2028

概要

加齢黄斑変性（AMD）市場は2023-2028年に51億米ドル、予測期間中のCAGRは6.54%で成長すると予測されます。

当レポートでは、加齢黄斑変性市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。AMDの高い有病率、AMD治療薬の強力なパイプラインと承認見込み、高齢者人口の増加などが市場を牽引しています。

本調査では、AMD治療におけるベンダーの戦略的提携が、今後数年間の加齢黄斑変性市場成長を牽引する主要因の1つであるとしています。また、AMD予防のための遺伝子治療の開発やAMDに対する意識の高まりも、市場の大きな需要につながると見込まれています。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場エコシステム

第3章 市場規模

• 市場の定義
• 市場セグメント分析
• 市場規模 2023
• 市場の見通し 2023-2028

第4章 市場規模実績

• 加齢黄斑変性の世界市場 2018-2022
• タイプセグメント分析 2018-2022
• 流通チャネルセグメント分析 2018-2022
• 地域別セグメント分析 2018-2022
• 国別セグメント分析 2018-2022

第5章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第6章 市場セグメンテーション：タイプ別

• 市場セグメント
• 比較：タイプ別
• 滲出型（ウェット型）AMD：市場規模と予測 2023-2028
• 萎縮型（ドライ型）AMD：市場規模と予測 2023-2028
• 市場機会：タイプ別

第7章 市場セグメンテーション：流通チャネル別

• 市場セグメント
• 比較：流通チャネル別
• 病院薬局：市場規模と予測 2023-2028
• 専門薬局：市場規模と予測 2023-2028
• オンライン薬局：市場規模と予測 2023-2028
• 市場機会：流通チャネル別

第8章 顧客情勢

• 顧客情勢の概要

第9章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• 北米：市場規模と予測 2023-2028
• 欧州：市場規模と予測 2023-2028
• アジア：市場規模と予測 2023-2028
• 世界のその他の地域：市場規模と予測 2023-2028
• 米国：市場規模と予測 2023-2028
• ドイツ：市場規模と予測 2023-2028
• 英国：市場規模と予測 2023-2028
• フランス：市場規模と予測 2023-2028
• 日本：市場規模と予測 2023-2028
• 市場機会：地域情勢別

第10章 促進要因、課題、および動向

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場動向

第11章 ベンダー情勢

• 概要
• ベンダー情勢
• 混乱の状況
• 業界のリスク

第12章 ベンダー分析

• 対象ベンダー
• ベンダーの市場ポジショニング
• AbbVie Inc.
• Alkeus Pharmaceuticals Inc.
• Amgen Inc.
• Apellis Pharmaceuticals Inc.
• Bausch Health Companies Inc.
• Bayer AG
• Bio Thera Bio Pharmaceutical Co. Ltd.
• Biocon Ltd.
• F. Hoffmann La Roche Ltd.
• IVERIC bio Inc.
• Lupin Ltd.
• Novartis AG
• Outlook Therapeutics Inc.
• Pfizer Inc.
• Regeneron Pharmaceuticals Inc.

第13章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Type
• Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits18: Historic Market Size - Data Table on global age-related macular degeneration (amd) market 2018 - 2022 ($ billion)
• Exhibits19: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
• Exhibits20: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ billion)
• Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
• Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
• Exhibits23: Five forces analysis - Comparison between 2023 and 2028
• Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
• Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
• Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
• Exhibits29: Chart on Market condition - Five forces 2023 and 2028
• Exhibits30: Chart on Type - Market share 2023-2028 (%)
• Exhibits31: Data Table on Type - Market share 2023-2028 (%)
• Exhibits32: Chart on Comparison by Type
• Exhibits33: Data Table on Comparison by Type
• Exhibits34: Chart on Wet AMD - Market size and forecast 2023-2028 ($ billion)
• Exhibits35: Data Table on Wet AMD - Market size and forecast 2023-2028 ($ billion)
• Exhibits36: Chart on Wet AMD - Year-over-year growth 2023-2028 (%)
• Exhibits37: Data Table on Wet AMD - Year-over-year growth 2023-2028 (%)
• Exhibits38: Chart on Dry AMD - Market size and forecast 2023-2028 ($ billion)
• Exhibits39: Data Table on Dry AMD - Market size and forecast 2023-2028 ($ billion)
• Exhibits40: Chart on Dry AMD - Year-over-year growth 2023-2028 (%)
• Exhibits41: Data Table on Dry AMD - Year-over-year growth 2023-2028 (%)
• Exhibits42: Market opportunity by Type ($ billion)
• Exhibits43: Data Table on Market opportunity by Type ($ billion)
• Exhibits44: Chart on Distribution Channel - Market share 2023-2028 (%)
• Exhibits45: Data Table on Distribution Channel - Market share 2023-2028 (%)
• Exhibits46: Chart on Comparison by Distribution Channel
• Exhibits47: Data Table on Comparison by Distribution Channel
• Exhibits48: Chart on Hospital pharmacy - Market size and forecast 2023-2028 ($ billion)
• Exhibits49: Data Table on Hospital pharmacy - Market size and forecast 2023-2028 ($ billion)
• Exhibits50: Chart on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
• Exhibits51: Data Table on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
• Exhibits52: Chart on Specialty pharmacy - Market size and forecast 2023-2028 ($ billion)
• Exhibits53: Data Table on Specialty pharmacy - Market size and forecast 2023-2028 ($ billion)
• Exhibits54: Chart on Specialty pharmacy - Year-over-year growth 2023-2028 (%)
• Exhibits55: Data Table on Specialty pharmacy - Year-over-year growth 2023-2028 (%)
• Exhibits56: Chart on Online pharmacy - Market size and forecast 2023-2028 ($ billion)
• Exhibits57: Data Table on Online pharmacy - Market size and forecast 2023-2028 ($ billion)
• Exhibits58: Chart on Online pharmacy - Year-over-year growth 2023-2028 (%)
• Exhibits59: Data Table on Online pharmacy - Year-over-year growth 2023-2028 (%)
• Exhibits60: Market opportunity by Distribution Channel ($ billion)
• Exhibits61: Data Table on Market opportunity by Distribution Channel ($ billion)
• Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits63: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits65: Chart on Geographic comparison
• Exhibits66: Data Table on Geographic comparison
• Exhibits67: Chart on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibits68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibits69: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibits70: Data Table on North America - Year-over-year growth 2023-2028 (%)
• Exhibits71: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibits72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibits73: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits75: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
• Exhibits76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
• Exhibits77: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
• Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
• Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits83: Chart on US - Market size and forecast 2023-2028 ($ billion)
• Exhibits84: Data Table on US - Market size and forecast 2023-2028 ($ billion)
• Exhibits85: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibits86: Data Table on US - Year-over-year growth 2023-2028 (%)
• Exhibits87: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibits88: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibits89: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits91: Chart on UK - Market size and forecast 2023-2028 ($ billion)
• Exhibits92: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
• Exhibits93: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibits94: Data Table on UK - Year-over-year growth 2023-2028 (%)
• Exhibits95: Chart on France - Market size and forecast 2023-2028 ($ billion)
• Exhibits96: Data Table on France - Market size and forecast 2023-2028 ($ billion)
• Exhibits97: Chart on France - Year-over-year growth 2023-2028 (%)
• Exhibits98: Data Table on France - Year-over-year growth 2023-2028 (%)
• Exhibits99: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
• Exhibits100: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
• Exhibits101: Chart on Japan - Year-over-year growth 2023-2028 (%)
• Exhibits102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
• Exhibits103: Market opportunity By Geographical Landscape ($ billion)
• Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ billion)
• Exhibits105: Impact of drivers and challenges in 2023 and 2028
• Exhibits106: Overview on Criticality of inputs and Factors of differentiation
• Exhibits107: Overview on factors of disruption
• Exhibits108: Impact of key risks on business
• Exhibits109: Vendors covered
• Exhibits110: Matrix on vendor position and classification
• Exhibits111: AbbVie Inc. - Overview
• Exhibits112: AbbVie Inc. - Product / Service
• Exhibits113: AbbVie Inc. - Key news
• Exhibits114: AbbVie Inc. - Key offerings
• Exhibits115: Alkeus Pharmaceuticals Inc. - Overview
• Exhibits116: Alkeus Pharmaceuticals Inc. - Product / Service
• Exhibits117: Alkeus Pharmaceuticals Inc. - Key offerings
• Exhibits118: Amgen Inc. - Overview
• Exhibits119: Amgen Inc. - Product / Service
• Exhibits120: Amgen Inc. - Key offerings
• Exhibits121: Apellis Pharmaceuticals Inc. - Overview
• Exhibits122: Apellis Pharmaceuticals Inc. - Product / Service
• Exhibits123: Apellis Pharmaceuticals Inc. - Key offerings
• Exhibits124: Bausch Health Companies Inc. - Overview
• Exhibits125: Bausch Health Companies Inc. - Business segments
• Exhibits126: Bausch Health Companies Inc. - Key news
• Exhibits127: Bausch Health Companies Inc. - Key offerings
• Exhibits128: Bausch Health Companies Inc. - Segment focus
• Exhibits129: Bayer AG - Overview
• Exhibits130: Bayer AG - Business segments
• Exhibits131: Bayer AG - Key news
• Exhibits132: Bayer AG - Key offerings
• Exhibits133: Bayer AG - Segment focus
• Exhibits134: Bio Thera Bio Pharmaceutical Co. Ltd. - Overview
• Exhibits135: Bio Thera Bio Pharmaceutical Co. Ltd. - Product / Service
• Exhibits136: Bio Thera Bio Pharmaceutical Co. Ltd. - Key offerings
• Exhibits137: Biocon Ltd. - Overview
• Exhibits138: Biocon Ltd. - Business segments
• Exhibits139: Biocon Ltd. - Key offerings
• Exhibits140: Biocon Ltd. - Segment focus
• Exhibits141: F. Hoffmann La Roche Ltd. - Overview
• Exhibits142: F. Hoffmann La Roche Ltd. - Business segments
• Exhibits143: F. Hoffmann La Roche Ltd. - Key news
• Exhibits144: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibits145: F. Hoffmann La Roche Ltd. - Segment focus
• Exhibits146: IVERIC bio Inc. - Overview
• Exhibits147: IVERIC bio Inc. - Product / Service
• Exhibits148: IVERIC bio Inc. - Key offerings
• Exhibits149: Lupin Ltd. - Overview
• Exhibits150: Lupin Ltd. - Product / Service
• Exhibits151: Lupin Ltd. - Key news
• Exhibits152: Lupin Ltd. - Key offerings
• Exhibits153: Novartis AG - Overview
• Exhibits154: Novartis AG - Business segments
• Exhibits155: Novartis AG - Key offerings
• Exhibits156: Novartis AG - Segment focus
• Exhibits157: Outlook Therapeutics Inc. - Overview
• Exhibits158: Outlook Therapeutics Inc. - Product / Service
• Exhibits159: Outlook Therapeutics Inc. - Key offerings
• Exhibits160: Pfizer Inc. - Overview
• Exhibits161: Pfizer Inc. - Product / Service
• Exhibits162: Pfizer Inc. - Key news
• Exhibits163: Pfizer Inc. - Key offerings
• Exhibits164: Regeneron Pharmaceuticals Inc. - Overview
• Exhibits165: Regeneron Pharmaceuticals Inc. - Product / Service
• Exhibits166: Regeneron Pharmaceuticals Inc. - Key offerings
• Exhibits167: Inclusions checklist
• Exhibits168: Exclusions checklist
• Exhibits169: Currency conversion rates for US$
• Exhibits170: Research methodology
• Exhibits171: Validation techniques employed for market sizing
• Exhibits172: Information sources
• Exhibits173: List of abbreviations

Abstract

The age-related macular degeneration market is forecasted to grow by USD 5.10 bn during 2023-2028, accelerating at a CAGR of 6.54% during the forecast period. The report on the age-related macular degeneration market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by high prevalence of AMD, strong pipeline and expected approvals of AMD therapeutics, and rising geriatric population.

Technavio's age-related macular degeneration market is segmented as below:

By Type

• Wet AMD
• Dry AMD

By Distribution Channel

• Hospital pharmacy
• Specialty pharmacy
• Online Pharmacy

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the strategic alliances by vendors to treat AMD as one of the prime reasons driving the age-related macular degeneration market growth during the next few years. Also, the development of gene therapy for preventing AMD and growing awareness of AMD will lead to sizable demand in the market.

The report on the age-related macular degeneration market covers the following areas:

• Age-related macular degeneration market sizing
• Age-related macular degeneration market forecast
• Age-related macular degeneration market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading age-related macular degeneration market vendors that include AbbVie Inc., Adverum Biotechnologies Inc., Alimera Sciences Inc., Alkeus Pharmaceuticals Inc., Amgen Inc., Apellis Pharmaceuticals Inc., Bausch Health Companies Inc., Bayer AG, Bio Thera Bio Pharmaceutical Co. Ltd., Biocon Ltd., F. Hoffmann La Roche Ltd., IVERIC bio Inc., Lupin Ltd., Novartis AG, Outlook Therapeutics Inc., Pfizer Inc., Regeneron Pharmaceuticals Inc., Ribomic Inc., Viatris Inc., and Xbrane Biopharma AB. Also, the age-related macular degeneration market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
• Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
• Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global age-related macular degeneration (AMD) market 2018 - 2022
• Exhibit 18: Historic Market Size - Data Table on global age-related macular degeneration (amd) market 2018 - 2022 ($ billion)
• 4.2 Type Segment Analysis 2018 - 2022
• Exhibit 19: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
• 4.3 Distribution Channel Segment Analysis 2018 - 2022
• Exhibit 20: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ billion)
• 4.4 Geography Segment Analysis 2018 - 2022
• Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
• 4.5 Country Segment Analysis 2018 - 2022
• Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Type

• 6.1 Market segments
• Exhibit 30: Chart on Type - Market share 2023-2028 (%)
• Exhibit 31: Data Table on Type - Market share 2023-2028 (%)
• 6.2 Comparison by Type
• Exhibit 32: Chart on Comparison by Type
• Exhibit 33: Data Table on Comparison by Type
• 6.3 Wet AMD - Market size and forecast 2023-2028
• Exhibit 34: Chart on Wet AMD - Market size and forecast 2023-2028 ($ billion)
• Exhibit 35: Data Table on Wet AMD - Market size and forecast 2023-2028 ($ billion)
• Exhibit 36: Chart on Wet AMD - Year-over-year growth 2023-2028 (%)
• Exhibit 37: Data Table on Wet AMD - Year-over-year growth 2023-2028 (%)
• 6.4 Dry AMD - Market size and forecast 2023-2028
• Exhibit 38: Chart on Dry AMD - Market size and forecast 2023-2028 ($ billion)
• Exhibit 39: Data Table on Dry AMD - Market size and forecast 2023-2028 ($ billion)
• Exhibit 40: Chart on Dry AMD - Year-over-year growth 2023-2028 (%)
• Exhibit 41: Data Table on Dry AMD - Year-over-year growth 2023-2028 (%)
• 6.5 Market opportunity by Type
• Exhibit 42: Market opportunity by Type ($ billion)
• Exhibit 43: Data Table on Market opportunity by Type ($ billion)

7 Market Segmentation by Distribution Channel

• 7.1 Market segments
• Exhibit 44: Chart on Distribution Channel - Market share 2023-2028 (%)
• Exhibit 45: Data Table on Distribution Channel - Market share 2023-2028 (%)
• 7.2 Comparison by Distribution Channel
• Exhibit 46: Chart on Comparison by Distribution Channel
• Exhibit 47: Data Table on Comparison by Distribution Channel
• 7.3 Hospital pharmacy - Market size and forecast 2023-2028
• Exhibit 48: Chart on Hospital pharmacy - Market size and forecast 2023-2028 ($ billion)
• Exhibit 49: Data Table on Hospital pharmacy - Market size and forecast 2023-2028 ($ billion)
• Exhibit 50: Chart on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
• Exhibit 51: Data Table on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
• 7.4 Specialty pharmacy - Market size and forecast 2023-2028
• Exhibit 52: Chart on Specialty pharmacy - Market size and forecast 2023-2028 ($ billion)
• Exhibit 53: Data Table on Specialty pharmacy - Market size and forecast 2023-2028 ($ billion)
• Exhibit 54: Chart on Specialty pharmacy - Year-over-year growth 2023-2028 (%)
• Exhibit 55: Data Table on Specialty pharmacy - Year-over-year growth 2023-2028 (%)
• 7.5 Online pharmacy - Market size and forecast 2023-2028
• Exhibit 56: Chart on Online pharmacy - Market size and forecast 2023-2028 ($ billion)
• Exhibit 57: Data Table on Online pharmacy - Market size and forecast 2023-2028 ($ billion)
• Exhibit 58: Chart on Online pharmacy - Year-over-year growth 2023-2028 (%)
• Exhibit 59: Data Table on Online pharmacy - Year-over-year growth 2023-2028 (%)
• 7.6 Market opportunity by Distribution Channel
• Exhibit 60: Market opportunity by Distribution Channel ($ billion)
• Exhibit 61: Data Table on Market opportunity by Distribution Channel ($ billion)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 9.2 Geographic comparison
• Exhibit 65: Chart on Geographic comparison
• Exhibit 66: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
• Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
• 9.4 Europe - Market size and forecast 2023-2028
• Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 9.5 Asia - Market size and forecast 2023-2028
• Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
• Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
• Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
• Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
• Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
• Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 9.7 US - Market size and forecast 2023-2028
• Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ billion)
• Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ billion)
• Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
• 9.8 Germany - Market size and forecast 2023-2028
• Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 9.9 UK - Market size and forecast 2023-2028
• Exhibit 91: Chart on UK - Market size and forecast 2023-2028 ($ billion)
• Exhibit 92: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
• Exhibit 93: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibit 94: Data Table on UK - Year-over-year growth 2023-2028 (%)
• 9.10 France - Market size and forecast 2023-2028
• Exhibit 95: Chart on France - Market size and forecast 2023-2028 ($ billion)
• Exhibit 96: Data Table on France - Market size and forecast 2023-2028 ($ billion)
• Exhibit 97: Chart on France - Year-over-year growth 2023-2028 (%)
• Exhibit 98: Data Table on France - Year-over-year growth 2023-2028 (%)
• 9.11 Japan - Market size and forecast 2023-2028
• Exhibit 99: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
• Exhibit 100: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
• Exhibit 101: Chart on Japan - Year-over-year growth 2023-2028 (%)
• Exhibit 102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
• 9.12 Market opportunity By Geographical Landscape
• Exhibit 103: Market opportunity By Geographical Landscape ($ billion)
• Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 105: Impact of drivers and challenges in 2023 and 2028
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 107: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 108: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 109: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 110: Matrix on vendor position and classification
• 12.3 AbbVie Inc.
• Exhibit 111: AbbVie Inc. - Overview
• Exhibit 112: AbbVie Inc. - Product / Service
• Exhibit 113: AbbVie Inc. - Key news
• Exhibit 114: AbbVie Inc. - Key offerings
• 12.4 Alkeus Pharmaceuticals Inc.
• Exhibit 115: Alkeus Pharmaceuticals Inc. - Overview
• Exhibit 116: Alkeus Pharmaceuticals Inc. - Product / Service
• Exhibit 117: Alkeus Pharmaceuticals Inc. - Key offerings
• 12.5 Amgen Inc.
• Exhibit 118: Amgen Inc. - Overview
• Exhibit 119: Amgen Inc. - Product / Service
• Exhibit 120: Amgen Inc. - Key offerings
• 12.6 Apellis Pharmaceuticals Inc.
• Exhibit 121: Apellis Pharmaceuticals Inc. - Overview
• Exhibit 122: Apellis Pharmaceuticals Inc. - Product / Service
• Exhibit 123: Apellis Pharmaceuticals Inc. - Key offerings
• 12.7 Bausch Health Companies Inc.
• Exhibit 124: Bausch Health Companies Inc. - Overview
• Exhibit 125: Bausch Health Companies Inc. - Business segments
• Exhibit 126: Bausch Health Companies Inc. - Key news
• Exhibit 127: Bausch Health Companies Inc. - Key offerings
• Exhibit 128: Bausch Health Companies Inc. - Segment focus
• 12.8 Bayer AG
• Exhibit 129: Bayer AG - Overview
• Exhibit 130: Bayer AG - Business segments
• Exhibit 131: Bayer AG - Key news
• Exhibit 132: Bayer AG - Key offerings
• Exhibit 133: Bayer AG - Segment focus
• 12.9 Bio Thera Bio Pharmaceutical Co. Ltd.
• Exhibit 134: Bio Thera Bio Pharmaceutical Co. Ltd. - Overview
• Exhibit 135: Bio Thera Bio Pharmaceutical Co. Ltd. - Product / Service
• Exhibit 136: Bio Thera Bio Pharmaceutical Co. Ltd. - Key offerings
• 12.10 Biocon Ltd.
• Exhibit 137: Biocon Ltd. - Overview
• Exhibit 138: Biocon Ltd. - Business segments
• Exhibit 139: Biocon Ltd. - Key offerings
• Exhibit 140: Biocon Ltd. - Segment focus
• 12.11 F. Hoffmann La Roche Ltd.
• Exhibit 141: F. Hoffmann La Roche Ltd. - Overview
• Exhibit 142: F. Hoffmann La Roche Ltd. - Business segments
• Exhibit 143: F. Hoffmann La Roche Ltd. - Key news
• Exhibit 144: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibit 145: F. Hoffmann La Roche Ltd. - Segment focus
• 12.12 IVERIC bio Inc.
• Exhibit 146: IVERIC bio Inc. - Overview
• Exhibit 147: IVERIC bio Inc. - Product / Service
• Exhibit 148: IVERIC bio Inc. - Key offerings
• 12.13 Lupin Ltd.
• Exhibit 149: Lupin Ltd. - Overview
• Exhibit 150: Lupin Ltd. - Product / Service
• Exhibit 151: Lupin Ltd. - Key news
• Exhibit 152: Lupin Ltd. - Key offerings
• 12.14 Novartis AG
• Exhibit 153: Novartis AG - Overview
• Exhibit 154: Novartis AG - Business segments
• Exhibit 155: Novartis AG - Key offerings
• Exhibit 156: Novartis AG - Segment focus
• 12.15 Outlook Therapeutics Inc.
• Exhibit 157: Outlook Therapeutics Inc. - Overview
• Exhibit 158: Outlook Therapeutics Inc. - Product / Service
• Exhibit 159: Outlook Therapeutics Inc. - Key offerings
• 12.16 Pfizer Inc.
• Exhibit 160: Pfizer Inc. - Overview
• Exhibit 161: Pfizer Inc. - Product / Service
• Exhibit 162: Pfizer Inc. - Key news
• Exhibit 163: Pfizer Inc. - Key offerings
• 12.17 Regeneron Pharmaceuticals Inc.
• Exhibit 164: Regeneron Pharmaceuticals Inc. - Overview
• Exhibit 165: Regeneron Pharmaceuticals Inc. - Product / Service
• Exhibit 166: Regeneron Pharmaceuticals Inc. - Key offerings

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 167: Inclusions checklist
• Exhibit 168: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 169: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 170: Research methodology
• Exhibit 171: Validation techniques employed for market sizing
• Exhibit 172: Information sources
• 13.5 List of abbreviations
• Exhibit 173: List of abbreviations